Ivonescimab (Anti-PD-1 & VEGF)
Product Specifications
CAS Number
2428381-53-5
Synonyms
AK 112, SMT 112
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Ivonescimab is a first-in-class humanized tetravalent bispecific antibody targeting PD-1 and VEGF-A, with immune checkpoint inhibitory, anti-angiogenic, and antineoplastic activities. It is being developed for the treatment of non-small cell lung cancer (NSCLC) and other solid tumors, including breast, liver, and gastric cancers. M.W 201.12 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470270-500 1x 500 µL
Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470009-500 1x 500 µL
MART-1 / Melan-A (M2-7C10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740900-100 1x 100 µL
Granulocyte-Colony Stimulating Factor (G-CSF) (CSF3) (CSF3/900), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741387-500 1x 500 µL
Ferritin, Light Chain (FTL) (Microglia Marker) (FTL/1387), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details